Home » Stocks » BSX

Boston Scientific Corporation (BSX)

Stock Price: $39.67 USD 0.14 (0.35%)
Updated Feb 25, 2021 4:00 PM EST - Market closed
After-hours: $39.92 +0.25 (0.63%) Feb 25, 5:14 PM
Market Cap 56.21B
Revenue (ttm) 9.91B
Net Income (ttm) -115.00M
Shares Out 1.42B
EPS (ttm) 2.61
PE Ratio 15.23
Forward PE 24.75
Dividend n/a
Dividend Yield n/a
Trading Day February 25
Last Price $39.67
Previous Close $39.53
Change ($) 0.14
Change (%) 0.35%
Day's Open 39.50
Day's Range 39.31 - 39.96
Day's Volume 11,651,678
52-Week Range 24.10 - 42.37

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Forbes - 1 day ago

We think that ​Henry Schein currently is a better pick compared to Boston Scientific. HSIC stock trades at about 0.9x trailing Revenues, compared to around 5.5x for Boston Scientific.

Other stocks mentioned: HSIC
Zacks Investment Research - 3 days ago

Rebound in sales volumes and rise in COVID-19 support products sales make us optimistic about MDT, MASI, XRAY and COO's results.

Other stocks mentioned: COO, HOLX, LH, MASI, MDT, XRAY
InvestorPlace - 1 week ago

Biotech stocks offer a textbook retracement pattern. The risk is low, and the reward is high.

Other stocks mentioned: IBB, XBI
InvestorPlace - 1 week ago

Whether in transportation, manufacturing or healthcare, don't touch any of these 14 AI-related stocks with a 10-foot pole. Here's why.

Other stocks mentioned: ATEX, BIIB, LUV, T, TNAV, XRX
PRNewsWire - 1 week ago

MARLBOROUGH, Mass., Feb. 12, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences. On February 25, 2021, Dan Brennan, executive ...

Zacks Investment Research - 2 weeks ago

Barring MedSurg, organic revenues at each of Boston Scientific (BSX) core segments and geographies are down in Q4 but the magnitude of this decline is lower than Q3.

Zacks Investment Research - 3 weeks ago

Apart from a drop in Q4 earnings and revenues drop year over year, Boston Scientific (BSX) also registers strong sequential decline in overall financial performance.

Zacks Investment Research - 3 weeks ago

Boston Scientific (BSX) delivered earnings and revenue surprises of -25.81% and -0.02%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the ...

Benzinga - 3 weeks ago

Shares of Boston Scientific (NYSE:BSX) fell 2.0% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 50.00% year over year to $0.23, whi...

PRNewsWire - 3 weeks ago

MARLBOROUGH, Mass., Feb. 3, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.708 billion during the fourth quarter of 2020. This represents a decline of...

Newsfile Corp - 3 weeks ago

New York, New York--(Newsfile Corp. - February 2, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secu...

Business Wire - 3 weeks ago

LOS ANGELES--(BUSINESS WIRE)---- $BSX #BSX--DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Boston Scientific Corporation

Newsfile Corp - 3 weeks ago

New York, New York--(Newsfile Corp. - February 2, 2021) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Boston Scientific Corporation (NYSE: BSX) b...

Newsfile Corp - 3 weeks ago

New York, New York--(Newsfile Corp. - February 1, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Boston Scientific Corporation (...

PRNewsWire - 3 weeks ago

LOS ANGELES, Feb. 1, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Boston Scientific Corporati...

Newsfile Corp - 3 weeks ago

New York, New York--(Newsfile Corp. - February 1, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...

GlobeNewsWire - 3 weeks ago

NEW YORK, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Boston Scientific C...

PRNewsWire - 3 weeks ago

NEW YORK, Feb. 1, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities cl...

GlobeNewsWire - 3 weeks ago

NEW YORK, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Boston Scientific Corporation (NYSE: BSX) between April 2...

PRNewsWire - 3 weeks ago

NEW YORK, Jan. 31, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: B...

Newsfile Corp - 3 weeks ago

New York, New York--(Newsfile Corp. - January 30, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Boston Scientific Corporation (NYSE: B...

Newsfile Corp - 3 weeks ago

New York, New York--(Newsfile Corp. - January 29, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...

Business Wire - 3 weeks ago

LOS ANGELES--(BUSINESS WIRE)---- $BSX #investors--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Boston Scientific Corporation (BSX)

Newsfile Corp - 4 weeks ago

New York, New York--(Newsfile Corp. - January 28, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Boston Scientific Corporation...

Newsfile Corp - 4 weeks ago

New York, New York--(Newsfile Corp. - January 28, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...

Zacks Investment Research - 4 weeks ago

Per Boston Scientific's (BSX) October update, it has started to see strong region-wise recovery.

Newsfile Corp - 4 weeks ago

New York, New York--(Newsfile Corp. - January 27, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Boston Scientific Corporation (...

Newsfile Corp - 4 weeks ago

New York, New York--(Newsfile Corp. - January 26, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...

Business Wire - 4 weeks ago

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Boston Scientific Corporation ("Boston Scientific" or the "C...

Newsfile Corp - 4 weeks ago

New York, New York--(Newsfile Corp. - January 26, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion...

Zacks Investment Research - 4 weeks ago

The latest FDA approval of Boston Scientific's (BSX) fourth-generation Vercise Genus DBS System is aimed at improving patients' quality of life.

The Motley Fool - 4 weeks ago

Amassing $1 million may be much more achievable than you think.

Other stocks mentioned: COST, ISRG
Newsfile Corp - 4 weeks ago

New York, New York--(Newsfile Corp. - January 25, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Boston Scientific Corporation (...

PRNewsWire - 4 weeks ago

NEW YORK, Jan. 25, 2021 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has filed a class action suit in the United States District Court for the District of Massachusetts agai...

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - January 25, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...

GlobeNewsWire - 1 month ago

NEW YORK, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Boston Scientific Corporation (NYSE: BSX) between April 2...

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - January 23, 2021) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Boston Scientific Corporation (NYSE: BSX) b...

GlobeNewsWire - 1 month ago

LOS ANGELES, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 2, 2021 deadline to file a lead plaintiff motion in the class acti...

Zacks Investment Research - 1 month ago

Boston Scientific's (BSX) acquisition of Preventice solutions enables the former to expand rhythm management diagnostics portfolio and abilities.

PRNewsWire - 1 month ago

MARLBOROUGH, Mass., Jan. 22, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval of its fourth-generation Vercise Genus...

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - January 21, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Boston Scientific Corporation (...

PRNewsWire - 1 month ago

NEW YORK, Jan. 21, 2021 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Boston Scientific Corporation (NYSE: BSX) between April 24, 2...

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - January 21, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...

Market Watch - 1 month ago

Boston Scientific Inc. said Thursday it has agreed to acquire privately held Preventice Solutions Inc. for an upfront payment of $925 million and up to $300 million in potential milestone paym...

PRNewsWire - 1 month ago

MARLBOROUGH, Mass., Jan. 21, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Preventice Solutions, Inc., a private...

The Motley Fool - 1 month ago

The pandemic is only a temporary setback for this diversified global manufacturer of medical devices.

Other stocks mentioned: BAX, MDT, SYK, TMO, XLV
Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - January 20, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Boston Scientific Corporation ("Boston Scientific" or the "...

PRNewsWire - 1 month ago

LOS ANGELES, Jan. 20, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise a...

Accesswire - 1 month ago

NEW YORK, NY / ACCESSWIRE / January 17, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you s...

Other stocks mentioned: KNDI, NERV
Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - January 15, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Boston Scientific Corporation (...

About BSX

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and r... [Read more...]

Industry
Medical Devices
IPO Date
May 18, 1992
CEO
Michael Mahoney
Employees
36,000
Stock Exchange
NYSE
Ticker Symbol
BSX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 27 analysts, the average rating for BSX stock is "Strong Buy." The 12-month stock price forecast is 43.36, which is an increase of 9.30% from the latest price.

Price Target
$43.36
(9.30% upside)
Analyst Consensus: Strong Buy